Shawna L. Weis

Statistics

Publications

Citations

271

H-Index

Active since

2017

Affiliations

Center for Drug Evaluation and Research(Current)

Shawna L. Weis is an author at Center for Drug Evaluation and Research specializing in oncology pharmacotherapy, melanoma pharmacotherapy, and response assessment.

ORCID

Publications per year

2017–2017

Publications

U.S. FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab

Maitreyee Hazarika, Meredith K. Chuk, Marc R. Theoret et al. · Clinical Cancer Research · 2017 · 182 citations

Medicine, Pharmacology, Pharmacotherapy +17

FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma

Meredith K. Chuk, Jennie Chang, Marc R. Theoret et al. · Clinical Cancer Research · 2017 · 89 citations

Medicine, Oncology, Pharmacology +17

1–2 of 2